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Craniofacial developmentR-spondins are a recently characterized family of secreted proteins that activate Wnt/β-catenin signaling.
Herein, we determine R-spondin2 (Rspo2) function in craniofacial development in mice. Mice lacking a
functional Rspo2 gene exhibit craniofacial abnormalities such as mandibular hypoplasia, maxillary and
mandibular skeletal deformation, and cleft palate. We found that loss of the mouse Rspo2 gene signiﬁcantly
disrupted Wnt/β-catenin signaling and gene expression within the ﬁrst branchial arch (BA1). Rspo2, which is
normally expressed in BA1 mesenchymal cells, regulates gene expression through a unique ectoderm–
mesenchyme interaction loop. The Rspo2 protein, potentially in combination with ectoderm-derived Wnt
ligands, up-regulates Msx1 and Msx2 expression within mesenchymal cells. In contrast, Rspo2 regulates
expression of the Dlx5, Dlx6, and Hand2 genes in mesenchymal cells via inducing expression of their upstream
activator, Endothelin1 (Edn1), within ectodermal cells. Loss of Rspo2 also causes increased cell apoptosis,
especially within the aboral (or caudal) domain of the BA1, resulting in hypoplasia of the BA1. Severely
reduced expression of Fgf8, a survival factor for mesenchymal cells, in the ectoderm of Rspo2−/− embryos is
likely responsible for increased cell apoptosis. Additionally, we found that the cleft palate in Rspo2−/−mice is
not associated with defects intrinsic to the palatal shelves. A possible cause of cleft palate is a delay of proper
palatal shelf elevation that may result from the small mandible and a failure of lowering the tongue. Thus, our
study identiﬁes Rspo2 as a mesenchyme-derived factor that plays critical roles in regulating BA1 patterning
and morphogenesis through ectodermal–mesenchymal interaction and a novel genetic factor for cleft palate.l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Craniofacial morphogenesis begins when cranial neural crest cells
delaminate from the dorsal neural tube and migrate ventrolaterally to
form the ectomesenchyme of the facial primordia including the
frontonasal prominence and branchial arches (Kontges and Lumsden,
1996; Lumsden et al., 1991; Osumi-Yamashita et al., 1994; Serbedzija
et al., 1992). In the mouse embryo, the ﬁrst branchial arch (BA1)
becomes apparent at E8.0–8.5 as small swellings on the side of the
developing head, and the BA1 increases rapidly in size as cranial
neural crest cells migrate into and proliferate within the arch
(Kaufman, 1992). While neural crest-derived cells are localized
immediately subadjacent to the covering surface ectoderm, myogenic
cells derived from the cranial paraxial mesoderm are more centrally
located (Trainor and Tam, 1995; Trainor et al., 1994). The BA1 further
divides into maxillary and mandibular components to give rise to
most skeletal elements of the jaw, teeth, lateral skull wall, palate, andmiddle ear, as well as part of the tongue and other soft tissue
derivatives (Chai et al., 2000; Chai and Maxson, 2006; Helms and
Schneider, 2003).
Previous experimental embryological studies suggest that devel-
opment of the BA1 mesenchyme is controlled by ectoderm-derived
signals that are responsible for cell proliferation, survival, patterning,
and differentiation (Cobourne and Sharpe, 2003; Francis-West et al.,
1994; Helms et al., 2005; Richman and Tickle, 1989; Trainor and
Krumlauf, 2001). Bone morphogenetic proteins (Bmps), ﬁbroblast
growth factors (Fgfs), and endothelin1 (Edn1) include the signaling
molecules expressed in the ectoderm of BA1 with a speciﬁc spatial
pattern (Chai and Maxson, 2006; Francis-West et al., 1998; Francis-
West et al., 1994; Kurihara et al., 1994; Trumpp et al., 1999; Tucker
et al., 1999a; Tucker et al., 1998). These signal cues trigger positive or
negative regulation of a diverse set of genes encoding transcription
factors, such as Dlx and Msx homeobox factors, in mesenchymal cells
that control patterning and morphogenesis of BA1-derived skeletal
structures (Depew et al., 2002; Depew et al., 2005; Satokata et al.,
2000; Satokata and Maas, 1994).
Strong canonical Wnt/β-catenin signaling activity is detected
within various craniofacial regions including the BA1 (Brugmann
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as TopGAL (DasGupta and Fuchs, 1999) or BATGAL (Maretto et al.,
2003). In the BA1, Wnt/β-catenin signaling activity is visible as early
as E8.5 and then is speciﬁcally detected within most of the maxillary
BA1 and a medial portion of the mandibular BA1 through E9.5–E11.5
(Brugmann et al., 2007). In support of Wnt/β-catenin signaling in BA1
patterning and morphogenesis, genetic deletion of the mouse Lrp6
gene encoding the co-receptor of canonical Wnt/β-catenin signaling
resulted in a systematic failure of proper development of craniofacial
structures (Pinson et al., 2000; Song et al., 2009). This failure in the Lrp6
mutant is associated with severe ablation of Wnt/β-catenin signaling
activity and disrupted regulation of Msx1 and Msx2 gene expression in
craniofacial primordial structures (Song et al., 2009). Several Wnt
ligand genes such as Wnt3, Wnt5a, and Wnt9b are expressed in
developing mouse craniofacial structures (Geetha-Loganathan et al.,
2009; Summerhurst et al., 2008) and also are associated with cleft
palate/lip phenotypes in human andmice (Blanton et al., 2004; Chiquet
et al., 2008; He et al., 2008; Juriloff et al., 2006; Niemann et al., 2004).
R-spondins (Rspo) are a novel class of cysteine-rich secreted
proteins that are structurally unrelated to the Wnt proteins and ac-
tivate the β-catenin signaling pathway (Binnerts et al., 2007; Kamata
et al., 2004; Kazanskaya et al., 2004; Kim et al., 2005a; Kim et al., 2008;
Nam et al., 2006; Wei et al., 2007). We found that Rspo2, a member of
the Rspo gene family, is expressed in mesenchymal cells of BA1, BA2,
and the nasal processes in mouse embryos (Nam et al., 2007b). Mice
lacking a functional Rspo2 gene developed various developmental
defects including cleft palate (Aoki et al., 2008; Nam et al., 2007a;
Yamada et al., 2009).
In this study, we report a systematic analysis of craniofacial de-
velopment in Rspo2 null mice. We found that Rspo2 is a key regulator
of canonical Wnt/β-catenin signaling and downstream gene expres-
sion in both ectoderm and mesenchyme in the BA1. Ex vivo gain-of-
function studies revealed a unique role of Rspo2 as a mesenchyme-
derived regulatory factor, in the signaling interaction between
ectoderm and mesenchyme of the BA1.
Materials and methods
Animals
Mice carrying the Rspo2 null (Rspo2−/−) allele was previously
described (Nam et al., 2007a) and maintained on a mixed C57BL/
6×129 background. A second mutant allele of the Rspo2 (Rspo2ΔZN)
gene in which the LacZ and neo gene cassettes were removed by Flp-
dependent recombination was generated as described in supplemen-
tary materials (Fig. S1). Rosa26+/Flp and TopGAL mice were obtained
from The Jackson Laboratory (Bar Harbor, ME). Lrp6+/−mice (Pinson
et al., 2000) were kindly provided by Dr. William Skarnes (Sanger
Institute, Cambridge, U.K.) and maintained on a mixed C57BL/6×C3H
background. The Rspo2 null, Rspo2ΔZN, and Lrp6 null alleles were
genotyped by polymerase chain reaction (PCR) as described (Nam
et al., 2007a; Pinson et al., 2000). Genotyping of TopGAL and Rosa26Flp
mice were performed according to protocols available from The
Jackson Laboratory. To activateWnt/β-catenin signaling in embryos in
utero, 30 μl of 1 M LiCl solution was intraperitoneally injected into
pregnant females three times at 8.5, 9.5, and 10.0 dpc (day post
coitum). A 1 M NaCl solution was used as control. Mice were housed
in a pathogen-free air barrier facility, and animal handling and
procedures were approved by the Maine Medical Center Institutional
Animal Care and Use Committee.
Skeletal preparation, β-galactosidase staining, and whole-mount in situ
hybridization
Skeletal preparations of E18.5 fetuses and whole-mount in situ
hybridization were performed as described (Nam et al., 2007a).To visualize expression of the LacZ gene encoding β-galactosidase (β-
gal), freshly collected embryos were ﬁxed with 0.2% glutaraldehyde
for 15 min at room temperature and stained with X-Gal substrate
(Invitrogen, Carlsbad, CA) overnight at 37 °C. The stained embryos
were processed as cryosections. Fetuses/embryos and the cryosec-
tions were photographed under StemiSV6 stereomicroscope (Zeiss,
Germany) and Axioskop microscope (Zeiss, Germany) using AxioCam
digital camera (Zeiss, Germany).
Cell apoptosis and proliferation
For 5-Bromo-2′-deoxy-uridine (BrdU) labeling, pregnant females
were injected intraperitoneally with 100 μl of BrdU solution (Zymed
Laboratories, South San Francisco, CA) per 10 g of body weight, and
the embryos were harvested 30 min after BrdU injection. Embryos
were processed for parafﬁn-embedded sections (5 μm) by standard
protocol, and immunohistochemical detection of BrdUwas performed
using a BrdU detection kit (Roche Applied Science, Indianapolis, IN)
according to the manufacturer's instruction.
TdT-mediated dUTP nick-end labeling (TUNEL) assay, and phos-
pho-histoneH3 and activated caspase3 immunostaining procedures
were performed on cryosections (10 μm). TUNEL assay was per-
formed using an in situ cell death detection kit (Roche Applied
Science) according to the manufacturer's instruction. Anti-phospho-
histoneH3 (1:100 dilution), anti-cleaved caspase3 (1:100 dilution),
and anti-β-catenin (1:100 dilution) antibodies were obtained from
Cell Signaling Technology (Beverly, MA). The processed sections
were appropriately counterstained with hematoxylin/eosin or 4′,6-
diamidino-2-phenylindole (DAPI).
Western blot and a real-time quantitative reverse
transcriptase-polymerase chain reaction (qRT-PCR) analyses
The ﬁrst branchial arches were dissected from wild type and
Rspo2−/− embryos at E10.5 and homogenized in a hypertonic lysis
buffer containing 20 mMHEPES (pH 7.4), 50 mMNaF, 0.2 mMMgCl2,
20% glycerol, 0.1% Triton X-100, 1 mM PMSF, 0.2 mM sodium
orthovanadate and 1× protease inhibitor cocktail set V (EMD
Chemicals, Gibbstown NJ). Tissue lysate was mixed with sucrose
solution (0.25 M sucrose, 1 mM EDTA) and centrifuged at 20,000g
relative centrifugal force (RCF) for 60 min at 4 °C to prepare a
cytosolic fraction. Antibodies against β-catenin (1:1000 dilution, BD
Pharmigen) and β-tubulin (for loading control, 1:1000 dilution,
Santa Cruz Biotechnology) were used in western blotting. Signals
were developed by using the Pierce Super Signal West Dura kit
(Thermo Scientiﬁc/Pierce, Rockford IL) and quantiﬁed using Image J
software.
Total RNA was isolated from the branchial arch dissections and
explants by using Trizol reagent (Sigma-Aldrich, St Louis MO). Two
microgram of total RNA was used in cDNA synthesis. The cDNA
equivalent to 40 ng total RNA was used for qRT-PCR. DNA sequences
of the primers used in qRT-PCR are listed in Table S1 in supplementary
materials.
Palatal shelf and branchial arch explant culture
Palatal shelf explant culture was performed as described previ-
ously (Jin and Ding, 2006). Brieﬂy, mouse palatal shelves at E13.5–
E14.0 were dissected out in cold α-MEM containing 25 mM HEPES.
The dissected palatal shelves were paired and placed in an organ
culture plate containing α-MEMmediumwith 0.1 μg/ml ascorbic acid
and cultured at 37 °C with 5% CO2 for up to 48 hours.
Branchial arch explant culture was performed as a hanging drop
culture. Branchial arch explants were isolated from E9.5–E10.5
embryos. Ectoderm and mesenchyme explants were prepared from
branchial arch explants by enzymatic digestion with dispase (2.4 U/
Fig. 1. Cleft of the secondary palate in Rspo2−/− mice. (A and B) Ventral view of the
palate in E18.5 fetuses. The lower jaw was removed for a better view. Cleft palate is
indicated by black arrow in panel B. (C–J) Histological analysis of secondary palate
development in mouse embryos at different gestation times. Coronal sections through
the oral cavity were stained with hematoxylin and eosin. In panel H, the palatal shelf
remained in vertical orientation in Rspo2−/− mouse is indicated by red arrow. Red
arrow in panel J indicates the gap between the unfused palatal shelves in the Rspo2−/−
mouse. Two wild type and two Rspo2−/− mice were analyzed for each time point.
Abbreviations: mc, Meckel's cartilage; mo, molar primordium; nc, nasal cavity; p,
palatal shelf; t tongue.
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cultured in α-MEM for up to 48 hours and stained for β-gal enzyme
activity or subjected to RNA isolation for qRT-PCR analysis.
Recombinant human RSPO2 (rhRSPO2) and mouse Wnt3a
(rmWnt3a) proteins and human Endothelin1 (hEDN1) peptides
were purchased from R&D systems (Minneapolis, MN) and added to
the explant culture as indicated.
Statistical analysis
The experimental data were analyzed by Student's t-test for two
group comparison or one-way analysis of variance (ANOVA) for
multiple comparisons followed by Dunnett's test. Statistical signiﬁ-
cance was set at pb0.05. In qRT-PCR, each sample was analyzed in
duplicate to ensure technical reproducibility. The average of the
technical duplicate was used as a sample value to calculate the mean
and standard mean error (SEM) of each group.
Results
Loss of Rspo2 caused craniofacial abnormalities including cleft palate
We and others previously reported that Rspo2 null mice develop
multiple defects in limb, lung, and craniofacial structures (Aoki et al.,
2008; Bell et al., 2008; Nam et al., 2007a; Yamada et al., 2009).
Approximately 71% of Rspo2−/− mice (n=15/21) collected at E18.5
exhibited a cleft phenotype of secondary palate without cleft lip
(Fig. 1A and B). We performed a systematic analysis to determine the
nature of craniofacial defects including cleft palate in Rspo2−/− mice.
Cleft palate is caused by various defects at different steps of
palatogenesis (Chai and Maxson, 2006; Stanier and Moore, 2004). To
investigate the stage(s) affected during palatogenesis in Rspo2−/−
mice, we performed histological analyses of Rspo2−/− embryos from
E12.5 to E15.5. Outgrowth and initial downward growth of the palatal
shelves occurred normally in Rspo2−/−mice at E12.5 (Fig. 1C and D).
The tongue of Rspo2−/−mice was smaller than that of wild type mice
(Fig. 1C and F). Between E13.5 and E14.5, the tongue in Rspo2−/−mice
failed to move downward, which resulted in an obstruction and delay
of bilateral, horizontal elevation of the palatal shelves (Fig. 1G and H).
Because the timing of palatal shelf elevation is critical to complete
palate formation (Chai and Maxson, 2006; Jiang et al., 2006), the
palatal shelves in Rspo2−/− mice remained unfused even after they
were eventually elevated at E15.5 (Fig. 1I and J).
To determine whether Rspo2−/− mice harbor any craniofacial
skeletal defects linked to cleft palate, we analyzed bone and cartilage
structures in the heads of Rspo2−/−mice at E18.5 (Fig. 2). The length of
Rspo2−/− skullswas slightly shorter, although thiswas not statistically
signiﬁcant compared to wild type mice (Fig. 2A, B, and M; n=12),
whereas the skull widths of wild type and Rspo2−/−mice were similar
(Fig. 2N). However, several defective ormissing craniofacial structures
were apparent in Rspo2−/−mice. Notably, the mandible and Meckel's
cartilage in Rspo2−/− mice were signiﬁcantly shorter than those of
wild type mice (Fig. 2C–F, P, and Q; n=12). Prior to the onset of
ossiﬁcation, Meckel's cartilage was shortened in Rspo2−/− mice at
E13.5 (Fig. S2). The coronoid processwas absent in Rspo2−/−mice, and
the condylar and angular processes were reduced and smaller in size
(Fig. 2G andH; n=12/12). The upper jaw length of Rspo2−/−micewas
also slightly reduced compared with that of wild type mice (Fig. 2O;
n=12). The palatine processes of Rspo2−/− mice were not fully
developed and remained unfused (Fig. 2I and J; n=9/12). The
zygomatic process of the maxilla was truncated, thickened, and
fused with the zygomatic process of the squamosal directly without
connection via the jugal bone (Fig. 2K and L; n=9/12). Skeletal
structures affected in Rspo2−/−mice are summarized in Table 1. Taken
together, these results indicate that Rspo2 function is required for
proper craniofacial skeletal development, especially for the develop-ment of skeletal components within the upper and lower jaws derived
from the BA1.
Cleft palate in Rspo2−/− mice is not caused by defects intrinsic to the
palatal shelves
To determine whether the cleft palate defect in Rspo2−/− mice is
intrinsic to the palatal shelves, we tested the fusion of the palatal
shelves of Rspo2−/−mice in palatal shelf explant culture. Each isolated
pair of the palatal shelves isolated from E13.5–E14.0 embryos was
placed in culture with the two segments just touching at the medial
edge in the original anterior–posterior orientation (Fig. S3A). The
palatal shelves from Rspo2−/−mice completely fused similar to those
explanted from wild type mice (Fig. S3B–E). Furthermore, no
Fig. 2. Craniofacial skeletal analysis of Rspo2−/− mice at E18.5. (A and B) Dorsal view of the skull stained with alcian blue and alizarin red for cartilage and bone, respectively. The
mandible was removed for a better view. M and N lines indicate length and width of the skull, respectively. (C and D) Lateral view of the skull. O and P lines indicate length of the
upper jaw and mandible, respectively. Dorsal (E and F) and lateral (G and H) views of the mandible are shown. Q line indicates the length of Meckel's cartilage. Black arrow in F
indicates the fusion between the mandible and squamous (sq) bone. Black arrows in H indicate an ectopic process in the dorsal surfaces of moa (molar alveolus of dentary) and an
absence of crp (coronoid process), respectively. (I amd J) Ventral view of the upper jaw. The mandible was removed for a better view. Black arrows indicate the abnormalities in the
palatal process of themaxilla (ppmx) bones. (K and L) Lateral view of isolated maxillary components. Black arrow indicates the direct fusion between the squamous (sq) andmaxilla
(mx) bones with missing jugal (jg) bone. Abbreviations: agp, angular process; bo, basioccipital; cdp, condylar process; crp, coronoid process; fmx, frontal process of maxilla; jg, jugal
bone; moa, molar alveolus of dentary; mx, maxilla; p, presphenoid; pl, palatine; pmx, premaxilla; ppmx, palatal process of maxilla; pppx, palatal process of premaxilla. (M–Q)
Measurement of various parameters for the skull dimension. The lengths of the skull (M), upper jaw (O), mandible (P) andMeckel's cartilage (Q) and the width of the skull (N) were
presented (n=12 for wild type and Rspo2−/− mice, respectively) as mean±SEM (standard error of mean). Statistical signiﬁcances were determined by Student's t-test.
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Rspo2 loci) and TopGAL transgene, a LacZ gene reporter for Wnt/β-
catenin signaling (DasGupta and Fuchs, 1999), was detected within
the palatal shelves (Fig. S3F–I). These results eliminate the possibility
that cleft palate in Rspo2−/−mice stems from an intrinsic defect of the
palatal shelves.Rspo2 actively regulates canonical Wnt/β-catenin signaling in the BA1
Because all of the defective skeletal components in Rspo2−/−mice
were derived from the BA1, we decided to examine Rspo2 and TopGAL
expression in the BA1 of mouse embryos in parallel. In E10.5 mouse
embryos, TopGAL expression was detected in Rspo2 expression
domains and the neighboring regions within the mandibular and
maxillary components of the BA1 and nasal processes (Fig. 3A–H).
While Rspo2 expressionwas primarily restricted inmesenchymal cellsTable 1
Multiple skeletal defects in Rspo2−/− mice at E18.5.
Structures Abnormality (n)
Mandible Small and shortened (12/12)
Meckel's cartilage Shortened (12/12)
Tympanic ring bones Shortened and thinner (12/12)
Palatine bones Cleft (9/12)
Palatal process of maxilla Cleft (9/12)
Zygomatic process of maxilla Truncated and thickened (12/12)
Molar alveolus of dentary Malformed (12/12)
Coronoid process (Crp) Absent (12/12)
Condylar process (Cdp) Small and shortened (12/12)
Angular process (Agp) Small and shortened (12/12)
Lower incisor Delayed (12/12)
Tongue Small and shortened (12/12)within the oral (rostral) region of the BA1 (Fig. 3D), TopGAL
expression was detected in both ectodermal and mesenchymal cells
(Fig. 3H).
To determine how loss of the Rspo2 gene affects canonical Wnt
signaling in developing craniofacial structures, we examined TopGAL
expression in Rspo2ΔZN/ΔZNmice (Fig. S1). At E10.5, TopGAL expression
in the mandibular and maxillary processes of the BA1 and the nasal
processes were signiﬁcantly reduced in Rspo2ΔZN/ΔZN (Fig. 3J, L, and N)
compared to wild type mice (Fig. 3I, K, and M). However, TopGAL
expression in the medial domain of the BA1, where relatively weak
expression of Rspo2 was observed (red arrows in Fig. 3A), was less
affected (Fig. 3L). When the ectoderm and mesenchyme of the BA1
were separated and stained for β-gal activity individually, reduced
TopGAL expressionwas observed in bothmesenchymal (Fig. 3P and R)
and overlaying ectodermal cells (Fig. 3O and Q). Although Rspo2 is
only expressed in mesenchymal cells, the reduction of TopGAL
expression was more signiﬁcant in ectodermal cells than in mes-
enchymal cells (Fig. 4O–R).
In addition to TopGAL expression, we determined β-catenin
protein expression within the BA1 by immunoﬂuorescent staining
and Western blotting. In immunoﬂuorescent staining, we found that
β-catenin expression was severely reduced in the BA1 of Rspo2−/−
embryo compared to wild type embryo (Fig. 3T and S).
Consistent with this result, cytosolic β-catenin protein level in the
BA1 of Rspo2−/− embryos was decreased to approximately 55% of the
level in wild type embryos as determined by Western blot analysis
(Fig. 3U and V). Expression of Axin2, a direct downstream target of
canonical Wnt/β-catenin signaling, was considerably reduced in the
BA1 of Rspo2−/− embryos compared to wild type embryos (Fig. 3W).
Furthermore, in utero treatment of LiCl, an activator of Wnt/β-catenin
signaling (by inhibiting glycogen synthase kinase 3β (GSK-3β))
rescued TopGAL expression in the BA1 and nasal processes of
Rspo2ΔZN/ΔZN embryos to the level comparable to that of wild type
embryos (Fig. S4). Therefore, we conclude that Rspo2 loss led to
Fig. 3. Disruption of Wnt/β-catenin signaling in Rspo2−/−mouse embryos. (A–H) Comparison between Rspo2 RNA expression (A–D, n=3) and β-gal expression of Wnt/β-catenin
signaling reporter, TopGAL (E–H, n=4), in E10.5 embryos. Frontal (A and E) and lateral (B and F) views of embryos are presented. Red arrow in panel A indicates the medial area
where weak Rspo2 expressionwas detected.White dotted lines C in panel A and G in panel E represent the plane of sections shown in panels C and G, respectively. The nasal (NP), the
maxillary (BAlmx), and mandibular (BA1md) processes are indicated by blue arrowheads in panels B and F. (C and G) Transverse cryosections obtained from embryos in panels A
and E. The lateral (l) andmedial (m) sides of BA1 are labeled. Boxed regions aremagniﬁed in panels D and H. Red arrows indicate ectodermal cells. (I–R) TopGAL expression (detected
by β-gal staining) inwild type (n=5) and Rspo2ΔZN/ΔZN (n=5) embryos.White dashed lines, M and N, in panels K and L represent the plane of sections shown in panels M and N. Red
arrows in panel J indicate the domains where reduced TopGAL expression was observed in Rspo2ΔZN/ΔZN embryos. The width of the TopGAL expression domain is indicated by solid
line bars in panels M and N. (O–R) Ectoderm (Ecto) and mesenchyme (Mes) of the BA1 were separated by enzymatic digestion before β-gal staining. Two wild type and two
Rspo2ΔZN/ΔZN embryos were used, respectively. Red arrow in panel Q indicates a signiﬁcant decrease of TopGAL expression in the BA1 ectoderm of Rspo2ΔZN/ΔZN embryo. Red dotted
lines in panel R indicate the presumed boundary of TopGAL expression in a wild type embryo. Red arrow in the same panel indicates the region where TopGAL expression is absent in
Rspo2ΔZN/ΔZN embryos. (S and T) Immunoﬂuorescent staining of β-catenin protein (red) in the BA1 of wild type (n=3) and Rspo2−/− (n=3) embryos at E10.5. The sections were
counterstained with DAPI for nuclei. White dotted boxes indicate the area showing a signiﬁcant reduction of β-catenin-positive cells. (U and V)Western blot analysis of cytosolic β-
catenin in the BA1 tissue lysates. β-tubulin level was analyzed for protein loading control. BA1s isolated from two embryos were combined for preparing each sample. β-catenin
protein level measured from the duplicated Western blot analysis was normalized by β-tubulin level and is presented as mean±SEM in panel V. Student's t-test was used to
determine statistical signiﬁcance (pb0.01). (W) Axin2 RNA expression in the BA1 tissues of wild type and Rspo2−/− embryos at E10.5 was analyzed by qRT-PCR. Samples were
prepared from four individual embryos and qRT-PCR was performed in duplicate per sample. RNA expression level was normalized by Gapdh expression. Relative RNA expression is
presented as mean±SEM. The indicated statistical signiﬁcance (pb0.05) was determined by Student's t-test.
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structures including the BA1.
Synergistic genetic interaction between the Rspo2 and Lrp6 genes exists
in the BA1-derived skeletal development
To further determine the connection between Rspo2 and theWnt/
β-catenin pathway, we examined genetic epistasis between the Rspo2
and Lrp6 genes by analyzing Fgf8 RNA expression and the craniofacial
skeletal phenotypes of compound mice carrying both the Rspo2 and
Lrp6mutant alleles at E10.5 and E18.5, respectively (Fig. 4). Both wild
type and Lrp6+/− embryos showed similar Fgf8 expression level in the
BA1 (Fig. 4A and B), whereas signiﬁcantly reduced Fgf8 expression
was detected in Rspo2−/− embryos (Fig. 4C). Fgf8 expression was
completely abolished in the BA1 of Rspo2−/−;Lrp6+/− embryos
(Fig. 4D).
Rspo2+/−;Lrp6+/− double heterozygous mice did not show any
abnormalities in craniofacial skeletal structure at E18.5 (data not
shown). However, Rspo2−/−;Lrp6+/− mice showed more severe
abnormalities than Rspo2−/− mice. Cleft palate was observed in all
Rspo2−/−;Lrp6+/−mice (n=7) including one animal with both cleft lip
and palate, a phenotype never detected in Rspo2−/− mice. Enhancedabnormalities were observed in the skeletal components including
mandibular and maxillary skeletons of Rspo2−/−;Lrp6+/− mice com-
pared to Rspo2−/− mice (Fig. 4G, H, K, and L). The lengths of the skull,
upper jaw, mandible, and Meckel's cartilage of Rspo2−/−;Lrp6+/−mice
were shorter than those of Rspo2−/−mice (Fig 4O–Q, n=5, respective-
ly), whereas the width of the skull was unchanged (Fig. 4N). Inter-
estingly, we failed to collect any double homozygous mice (Rspo2−/−;
Lrp6−/−) at E18.5, suggesting that they may be embryonic lethal. This
genetic epistasis analysis shows that loss of the Rspo2 gene sensitizes a
dosage effect of the Lrp6 receptor in the BA1 and conﬁrms that Rspo2
functions in theWnt/β-catenin signaling pathwaymediated by the Lrp6
receptor.
Loss of Rspo2 leads to speciﬁc gene expression change within the BA1
mesenchyme
To determine how loss of Rspo2 modiﬁes gene regulation within
the BA1, we examined RNA expression of several genes implicated in
the morphogenesis and patterning of the BA1 in Rspo2−/− embryos at
E9.5 and E10.5 (Fig. 5). The Dlx genes encode homeobox transcription
factors that are implicated in mammalian jaw patterning based on
their nested expression patterns in the BA1 and the craniofacial
Fig. 4. Genetic interaction between the Rspo2 and Lrp6 genes during BA1-derived skeletal development. (A–D) Fgf8 RNA expression of E10.5 embryos was analyzed by whole-mount
in situ hybridization. Three embryos of each genotype were analyzed. Red arrows indicate reduced Fgf8 expression within the BA1 and nasal processes. (E–H) Lateral views of the
skulls at E18.5. (I–L) Lateral views of the mandibles at E18.5. Black arrows indicate the reduced or missing condylar and coronoid processes. Black asterisks indicate ossiﬁcation
of molar alveolus of dentary (moa). Wild type (Rspo2wt/wt;Lrp6wt/wt, A, E, and I), Lrp6 heterozygous mutant (Rspo2wt/wt;Lrp6wt/-, B, F, and J), Rspo2 homozygous mutant (Rspo2−/−;
Lrp6wt/wt, C, G, and K), and compound mouse homozygous for Rspo2 and heterozygous for Lrp6mutant alleles (Rspo2−/−;Lrp6wt/-, D, H, and L) were shown. (M–Q) Measurement of
various parameters for the skull dimension. The lengths of the skull (M), upper jaw (O), mandible (P), andMeckel's cartilage (Q) and the width of the skull (N) weremeasured (n=5
for wild type, Lrp6 heterozygous mutants and compound mice homozygous for Rspo2 and heterozygous for Lrp6mutant alleles, and n=4 for Rspo2 homozygous mice, respectively).
We noticed that, unlike in Fig. 2, the length of the upper jaw of wild type and Rspo2−/−mice was similar in this collection. This difference may be due to genetic background (amixed
C57BL/6×129 in Fig. 2 and a mixed C57BL/6×129×C3H in this ﬁgure) and smaller sample size. Statistical signiﬁcances were calculated by one-way ANOVA.
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2008). In Rspo2−/− embryos, neither Dlx1 nor Dlx3 expression was
affected (Fig. S5A–D). Conversely, Dlx5 and Dlx6 expression was
signiﬁcantly reduced within the oral–medial region of Rspo2−/− em-
bryos, whereas more lateral expression was less affected (Fig. 5A–D).
We also observed that Dlx5 expression was down-regulated in the
nasal processes of Rspo2−/− embryos (red star in Fig. 5B) with an
interesting unilateral pattern. Approximately 50% of Rspo2−/− em-
bryos displayed this pattern, and the reduced expressionwas detected
in the right nasal process.
The Hand1 (eHAND) and Hand2 (dHAND) genes encode basic
helix–loop–helix transcription factors. Hand1 expression in the most
medial region of the BA1 was down-regulated in Rspo2−/− embryos
(Fig. 5E and F). Hand2 is a direct target gene of Dlx5 and Dlx6 in the
BA1 (Charite et al., 2001; Ozeki et al., 2004). Consistent with reduced
Dlx5 and Dlx6 expression in Rspo2−/− embryos, Hand2 expression
within the BA1 was severely reduced in Rspo2−/− embryos at E9.5
(Fig. 5G and H).
Both Msx1 and Msx2 are expressed in the neural crest-derived
mesenchyme of the BAs and median nasal processes (Alappat et al.,
2003; Gauchat et al., 2000; Ishii et al., 2005). Expression of the Msx1
and Msx2 genes was signiﬁcantly reduced in Rspo2−/− embryos
(Fig. 5I–L). Expression of Msx1, but not Msx2, was speciﬁcally down-
regulated in Hand2 null mice (Thomas et al., 1998). Our results
suggest that reducedMsx1 expressionwithin the BA1may be partiallydue to the reduced Hand2 expression. Recently, both Msx1 and Msx2
were identiﬁed as direct canonical Wnt signaling targets in Lrp6 null
mice (Song et al., 2009). Therefore, Rspo2 and canonicalWnt signaling
may directly regulate Msx1 and Msx2 expression in both Hand2-
dependent and independent manners. Similar to Dlx5, bothMsx1 and
Msx2 in the nasal processes of Rspo2−/− embryos also were expressed
unilaterally (red stars in Fig. 5J and K).
To determine how the loss of Rspo2 affects oral–aboral polarity of
the mandibular BA1, we analyzed expression of the Gsc gene, an
aboral mandibular BA1-speciﬁc marker (Gaunt et al., 1993; Tucker
et al., 1999a). Gsc expression was extendedmore into the oral domain
in Rspo2−/− embryos (Fig. 5M and N), indicating a possible disruption
of oral mesenchymal speciﬁcity. This result also suggests that Rspo2-
mediated Wnt/β-catenin signaling may negatively control Gsc
expression.
To conﬁrm reduced RNA expression of several marker genes
quantitatively, we performed qRT-PCR with RNA samples isolated
from the BA1 of wild type and Rspo2−/− embryos at E10.5. Consistent
with whole-mount in situ hybridization results, Dlx5, Dlx6, Hand1,
Hand2, Msx1, and Msx2 RNA levels were signiﬁcantly reduced
(Fig. 5O). Interestingly, Gsc RNA level was not signiﬁcantly affected,
although its expression domain was expanded. Therefore, we
concluded that loss of Rspo2 gene caused a disruption of the speciﬁc
gene expression pattern within the mesenchyme of the BA1 and nasal
processes.
Fig. 5. Disruption of BA1 patterning in Rspo2−/− embryos. (A–N) Rspo2−/− and companion wild type embryos at E9.5–E10.5 were subjected to whole-mount in situ hybridization
analysis to determine marker gene expression. Dlx5 (A and B; wild type, n=4 and Rspo2−/−, n=5), Dlx6 (C and D; wild type, n=3 and Rspo2−/−, n=3), Hand1 (E and F; wild type,
n=3 and Rspo2−/−, n=3),Hand2 (G and H; wild type, n=6 and Rspo2−/−, n=5),Msx1 (I and J; wild type, n=6 and Rspo2−/−, n=5),Msx2 (K and L; wild type, n=2 and Rspo2−/−,
n=3), and Gsc (M and N; wild type, n=3 and Rspo2−/−, n=3) RNA expression was analyzed. Rspo2ΔZN/ΔZN embryo is shown in panel H. All frontal views are presented. Blue
arrowheads in panel A indicate the nasal process (NP) and the maxillary (BA1max) and mandibular (BA1md) processes of the BA1. Red stars and arrows indicate reduced gene
expression in the NP and the BA1, respectively. Red and yellow bars in panels M and N indicate the oral–aboral length of the BA1 and the range of Gsc RNA expression within the BA1,
respectively. (O) qRT-PCR analysis of marker gene RNA expression in the BA1 tissues of wild type and Rspo2−/− embryos at E10.5. Samples were prepared in quadruplicate and qRT-
PCR was performed in duplicate per sample. Expression level was normalized by Gapdh expression. Relative RNA expression level is presented as mean±SEM. Statistical
signiﬁcances were determined by Student's t-test and are indicated as *pb0.05 and **pb0.01, respectively.
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of Rspo2−/− mice
Decreased TopGAL expression within the BA1 ectoderm of Rspo2
mutant embryos (Fig. 3O and Q) raises the strong possibility that
Rspo2 is a paracrine factor for ectodermal cells. To test this possibility,
we examined expression of the Edn1, Fgf8, Bmp4, and Shh genes
encoding key signaling molecules within the BA1 ectoderm.
The Edn1–Endra signaling pathway plays a key role in craniofacial
development and also regulates Dlx5/Dlx6 and Hand2 expression
(Fukuhara et al., 2004; Ivey et al., 2003; Ozeki et al., 2004; Thomas
et al., 1998). Because Dlx5, Dlx6, and Hand2 expression was decreased
in Rspo2−/−mice (Fig. 5), the Edn1–EdnrA signaling pathway may be
disrupted in Rspo2−/−mice. Edn1 and Ednra expressionwas examined
in mouse embryos at E9.0, a critical time for Edn1-mediated signaling
in the BA1 (Fukuhara et al., 2004; Ruest and Clouthier, 2009). Edn1expression, especially in ectodermal cells of the oral side of the BA1,
was notably down-regulated in Rspo2−/− embryos (Fig. 6A–D). In
contrast, expression of the Ednra receptor gene was largely unaffected
in Rspo2−/− embryos (Fig. S5E and F).
Fgf8 is a key signaling molecule secreted from the oral ectodermal
cells of the BA1 and its expression is required to induce or maintain
expression of several different genes in the mandibular BA1, in
particular for mesenchymal cell survival and differentiation (Trumpp
et al., 1999; Tucker et al., 1999a). Fgf8 expression was severely
reduced in the BA1 of Rspo2−/− embryos at E9.0 (Fig. 6E and F) and
remained reduced in the frontal nasal, maxillary, and mandibular
processes at E10.5 (Figs. 4C and 6G and H).
BMP signaling is a positive regulator for the Msx1 and Msx2 genes
(Liu et al., 2005). Bmp4 expression was reduced in the BA1 ectoderm
of Rspo2−/− embryos (Fig. 6I and J). Furthermore, Bmp4 expression in
the nasal processes of Rspo2−/− embryoswas notably reducedwith an
Fig. 6. Reduced ectoderm-speciﬁc gene expression and increased cell apoptosis in the BA1 of Rspo2−/− embryos. RNA expression of the Edn1 (A–D; wild type, n=3 and Rspo2−/−,
n=3), Fgf8 (E–H; wild type, n=8 and Rspo2−/−, n=7), and Bmp4 (I and J; wild type, n=4 and Rspo2−/−, n=4) genes was analyzed by whole-mount in situ hybridization at E9.0
and E10.5. White dashed lines in panels A and B represent the planes of the sections presented in panels C and D, respectively. Rspo2ΔZN/ΔZN embryo is shown in panel F. (K–M) qRT-
PCR analysis of RNA expression. Edn1(K), Fgf8 (L), and Bmp4 (M) RNA levels in the BA1 of E10.5 mouse embryos were analyzed. The BA1 tissues were collected in quadruplicate and
qRT-PCR was performed in duplicate per sample. Expression level was normalized by Gapdh expression. Relative RNA expression level is presented as mean±SEM. Statistical
signiﬁcances were determined by Student's t-test and are indicated. (N–U) Black dashed lines in panel N represent the planes of the sections presented in panels O–T. Transverse
sections of E10.5 embryos at the level of the mandibular BA1 were stained for TUNEL (O–R) and a cleaved form of caspase3 (Casp3) (S and T). The sections were counterstained with
DAPI for nuclei. White arrows in panels P and R indicate apoptotic cells. White dashed boxes in panels S and T indicate the areas where the apoptotic cells were counted.
(U) Increased apoptosis in Rspo2−/−mice. More than 1500 total nuclei in each section prepared fromwild type (n=3) and Rspo2−/− embryos (n=2) were counted. Abbreviations:
BA1, the ﬁrst branchial arch; BA2, the second branchial arch; np, nasal process; oc, oral cavity.
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Msx1, and Msx2 down-regulation in this domain (Fig. 5B, J, and L). In
contrast, expression of the Shh gene, whose function is required for
midfacial and mandible development (Jeong et al., 2004), was not
altered in Rspo2−/− embryos (Fig. S5G and H).
Additionally, down-regulation of Edn1, Fgf8, and Bmp4 expression
in the BA of Rspo2−/− embryos was also conﬁrmed by qRT-PCR
analysis (Fig. 6K–M). Taken together, our results strongly suggest that
Rspo2 is a mesenchyme-derived paracrine factor for ectodermal cells
and regulates expression of several signaling molecules.
Increased cell apoptosis in the aboral mesenchymal cells of the BA1 of
Rspo2−/− embryos
Hypoplasia of the BA1 and a reduced expression of cell survival
factors such as Fgf8 in Rspo2−/− embryos led us to examine whether
the hypoplasia was induced by reduced cell proliferation or increased
cell death or both. Cell apoptosis (detected by both TUNEL and
activated caspase3 immunostaining) signiﬁcantly increased in the
BA1 of Rspo2−/− mice (Fig. 6O–U). Interestingly, most apoptotic cells
were localized in the aboral region of the BA1 (Fig. 6R, T, and U),
although most of reduced gene expression in Rspo2−/− embryos was
detected in the more oral side of the BA1 (Figs. 5 and 6).
For cell proliferation, we examined BrdU incorporation in dividing
cells after BrdU pulse labeling in vivo and expression of phospho-histoneH3, a marker for mitosis. No signiﬁcant change in BrdU or
phospho-histoneH3-positive cell number was observed in either the
oral (rostral) or aboral (caudal) side of the BA1 in Rspo2−/− embryos
at E10.5 (Fig. S6). Therefore, we conclude that BA1 hypoplasia in
Rspo2−/− embryos is primarily caused by increased cell apoptosis.Speciﬁc ectoderm–mesenchyme signaling interaction regulated by Rspo2
To determine whether Rspo2 directly induces canonical Wnt
signaling activation in the BA1, we cultured whole BA1 explants
isolated from TopGAL mice in the presence of recombinant human
RSPO2 protein (rhRSPO2) (Fig. 7A). The rhRSPO2 protein induced
expansion and increase of β-gal expression in the explants compared
to control (Fig. 7B–E). This increase was detected in both ectodermal
and underlying mesenchymal cells (Fig. 7E).
To determine whether exogenous rhRSPO2 induces genes whose
expression were down-regulated in Rspo2−/− embryos in the BA1, we
cultured whole BA1 explants dissected from E9.5 embryos in the
presence of rhRSPO2 and analyzed gene expression by qRT-PCR
(Fig. 7F). The rhRSPO2 protein effectively induced expression of the
TopGAL and Axin2 genes. Furthermore, multiple ectodermal and
mensenchymal genes whose expression were reduced in Rspo2−/−
embryos were effectively induced in the explants cultured in the
presence of exogenous rhRSPO2 (Fig. 7F).
Fig. 7. Rspo2-mediated activation of Wnt/β-catenin signaling and gene expression via ectoderm–mesenchyme interaction. (A) A schematic diagram of BA1 explant culture. (B–E)
Whole-mount β-gal staining of BA1 explants cultured in the presence of bovine serum albumin (BSA, 800 ng/ml, n=3) or rhRSPO2 protein (800 ng/ml, n=3). Orientation of the
explants is indicated oral–aboral (O–A) or rostral–caudal (R–C) and lateral–medial (L-M).White dashed lines in panels B and D represent the planes of the sections shown in panels C
and E, respectively. (F) Gene expression analysis by qRT-PCR of BA1 explants cultured in the presence of BSA or rhRSPO2. (G and H)Whole-mount β-gal staining of BAl mesenchymal
explants. Orientation of the explants is similar to panel B. Three explants were examined in culture containing BSA or rhRSPO2. (I–K) qRT-PCR analysis of gene expression in BA1
mesenchymal (I and J) and ectodermal (K) explants cultured in the presence of the rhRSPO2 (800 ng/ml) or rmWnt3a (50 ng/ml) or both proteins. (L) qRT-PCR analysis of gene
expression in BA1 mesenchymal explants cultured in the absence or presence of human EDN1 peptide (400 ng/ml). qRT-PCR samples were prepared in triplicate and qRT-
PCR was performed in duplicate per sample. Expression level was normalized by Gapdh expression. Relative expression level compared to the BSA treated samples is presented as
mean±SEM. Statistical signiﬁcances were determined by Student's t-test and are indicated as *pb0.05, **pb0.01, and ***pb0.005, respectively.
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enchymal and ectodermal cells respectively, mesenchymal and ectoder-
mal explantswere prepared from TopGAL embryos at E10–E10.5 (Fig. 7A)
and were cultured in the absence or presence of the rhRSPO2 protein.
Interestingly and unexpectedly, we failed to observe any signiﬁcant
increase or expansion of β-gal expression by rhRSPO2 treatment in the
mesenchymal explants (Fig. 7G and H). Consistent with this β-gal
staining result,Axin2 and TopGAL gene expressionwas not inducedby the
rhRSPO2 protein (Fig. 7I). Neither theMsx1norMsx2 gene, the targets for
canonical Wnt/β-catenin signaling (Song et al., 2009), was efﬁciently
induced by rhRSPO2 (Fig 7I). In contrast, TopGAL and Axin2 expression
was markedly increased in ectodermal explants treated with rhRSPO2
(Fig. 7K), indicating Wnt/β-catenin signaling activation. Fgf8 and Edn1
expressionwas also induced by rhRSPO2 in ectodermal explants (Fig. 7K).
To determine whether mesenchyme explants efﬁciently respond to
theWnt ligand, we analyzed gene expression inmesenchymal explants
incubated with recombinant mouse Wnt3a (rmWnt3a) protein. The
rmWnt3a protein has been used as a standard Wnt ligand that induces
Wnt/β-catenin signaling in many cell types. Although Wnt3a is not
expressed in the BA1 ectoderm,we reasoned that the rmWnt3a proteinmimics the canonicalWnt ligand expressed in theBA1. Interestingly, the
rmWnt3a protein effectively increased Wnt/β-catenin signaling in
mesenchymal explants exempliﬁed by the induction of TopGAL and
Axin2 gene expression (Fig. 7I). Similar to Axin2 and TopGAL, Msx1 and
Msx2 gene expression also was efﬁciently induced by the rmWnt3a
protein (Fig. 7I). We conclude that the Wnt/β-catenin signaling
pathway is intact and functional in BA1 mesenchymal cells.
Why is the rhRSPO2 protein unable to activate Wnt/β-catenin
signaling in mesenchymal explants? Previously, we and others showed
synergistic activity between the Rspo andWnt proteins in activation of
canonicalWnt signaling (Binnerts et al., 2007; Li et al., 2009; Nam et al.,
2006). Because mesenchymal cells express endogenous Rspo2, it is
possible that the exogenous rmWnt3a protein may efﬁciently activate
Wnt/β-catenin signaling in the mesenchyme in cooperation with the
endogenous Rspo2 protein. In contrast, the exogenous rhRSPO2 protein
cannot induce a robust Wnt signaling activation in mesenchymal
explants because no Wnt ligand is available.
To test whether Rspo2 and Wnt synergistically activates canonical
Wnt signaling in mesenchymal cells, we co-treated mesenchymal
explants with rhRSPO2 and rmWnt3a proteins. As expected,
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enhanced Axin2, Msx1, and Msx2 expression (Fig. 7I). We conclude
that synergy between the Rspo2 and Wnt proteins is likely required
for robust activation of Wnt/β-catenin signaling in BA1 mesenchymal
cells.
Interestingly, Dlx5, Dlx6, and Hand2 expression was not enhanced
by rhRSPO2, or rmWnt3a or both in mesenchymal explants (Fig. 7J).
This result suggests that their expression in the BA1 mesenchyme is
independent of Wnt/β-catenin signaling. Dlx5, Dlx6, and Hand2
expressions are regulated by Edn1 signaling (Ozeki et al., 2004;
Thomas et al., 1998). Edn1 expression was down-regulated in the BA1
ectoderm of Rspo2−/− embryos (Fig. 6) and was activated by rhRSPO2
in the BA1 ectodermal explants (Fig. 7K), thereby raising the
compelling possibility that Edn1 induced by rhRSPO2 in the BA1
ectoderm can activate the Dlx5, Dlx6, and Hand2 genes in the BA1
mesenchyme. Consistent with this possibility, exogenous human
EDN1 (hEDN1) peptide efﬁciently activated Dlx5, Dlx6, and Hand2
expression in mesenchymal explants (Fig. 7L). Conversely, the hEDN1
peptides failed to activate eitherMsx1 orMsx2 expression in the same
mesenchymal explants (Fig. 7L). Taken together, we conclude that
Rspo2 is a BA1 mesenchyme-derived canonical Wnt signaling
activator that speciﬁcally regulates gene expression in both an
autocrine and paracrine fashion.
Discussion
Regulation of Wnt/β-catenin signaling in the BA1 ectoderm and
mesenchyme
During BA1 development, signaling molecules produced from the
ectoderm usually activate downstream signaling events including
gene expression within the mesenchyme, and these signaling
interactions are essential for the proper patterning and morphogen-
esis of the BA1 and its derived skeletal structures (Chai and Maxson,
2006; Ferguson et al., 2000; Francis-West et al., 1998). In Rspo2−/−
embryos, the Wnt/β-catenin signaling responsive domain was
signiﬁcantly reduced in both the ectoderm and mesenchyme
(Fig. 3). Because Rspo2 is expressed in the mesenchyme (Fig. 3), this
result suggests that Rspo2 acts as both a paracrine factor for
ectodermal cells and an autocrine signal for mesenchymal tissue.
Indeed, the rhRSPO2 protein induced a dramatic increase of Wnt/β-
catenin signaling responsiveness in both the ectoderm and mesen-
chyme inwhole BA1 explants (Fig. 7E). Furthermore, a robust increase
of Wnt/β-catenin signaling in ectoderm explants by the exogenous
rhRSPO2 protein strongly suggests that Rspo2 is a mesenchyme-
derived paracrine factor for the BA1 ectoderm (Fig. 7K).
Surprisingly, rhRSPO2 failed to effectively activate Wnt/β-catenin
signaling in mesenchymal explants (Fig. 7G–I). How is Wnt/β-catenin
signaling induced by rhRSPO2 in mesenchymal cells of whole BA1
explants? Assuming that ectodermal cells can be directly stimulated
by the rhRSPO2 protein in whole BA1 explant culture (Fig. 7B–D), we
speculate that the rhRSPO2 protein may induce an ectoderm-derived
signal (likely Wnts) that can further induce Wnt/β-catenin signaling
in mesenchymal cells. Several Wnt genes including Wnt3 and Wnt9b
are expressed in the BA1 ectoderm (Geetha-Loganathan et al., 2009;
Lan et al., 2006; Summerhurst et al., 2008). Mutations in these two
genes are associated with craniofacial defects including cleft palate in
human and mice (Blanton et al., 2004; Chiquet et al., 2008; Juriloff
et al., 2006), suggesting that these Wnts are excellent candidates that
can be induced by Rspo2. Interestingly, Wnt9b expression in
the BA1 of Rspo2−/− embryos was weakly but signiﬁcantly reduced
(Fig. S7C–E), whereas Wnt3 expression was not affected (Fig. S7A, B,
and E). It remains to be determined if Rspo2 activates Wnt9b
expression (and possibly other Wnts) in the BA1 ectoderm and if
Wnt9b can activate Wnt/β-catenin response in the BA1 mesenchyme.
The rmWnt3a protein (used as a generic Wnt/β-catenin signalingactivator) induced mild but efﬁcient activation of Wnt/β-catenin
signaling in mesenchyme explants (Fig. 7I), strongly supporting the
possibility that ectoderm-derived Wnts such as Wnt9b protein can
generate similar activation of Wnt/β-catenin signaling in the BA1
mesenchyme.
The Rspo and Wnt proteins synergistically activate Wnt/β-catenin
signaling in other cell systems (Binnerts et al., 2007; Kazanskaya et al.,
2004; Kim et al., 2005a; Li et al., 2009; Nam et al., 2006), although the
underlying molecular mechanism is still unclear. If a similar
synergistic relationship exists in the BA1, it is possible that co-
operative action betweenmesenchyme-derived Rspo2 and ectoderm-
derivedWnt is required for activeWnt/β-catenin signaling in the BA1.
In support of this possibility, when mesenchymal explants were co-
treated with the rhRSPO2 and rmWnt3a proteins, a signiﬁcantly
higher Wnt/β-catenin activation was detected compared to the
explants incubated with the rhRSPO2 or rmWnt3a protein alone
(Fig. 7I). This result also may explain why the BA1 ectoderm and
mesenchyme respond to rhRSPO2 differentially (Fig. 7). In ectodermal
explants, endogenously expressed Wnt can generate a robust Wnt/β-
catenin response in cooperation with exogenously provided rhRSPO2
(Fig. 7K). In contrast, exogenous rhRSPO2 cannot induce robust Wnt/
β-catenin activation in mesenchymal explants where no sufﬁcient
Wnt is intrinsically expressed (Fig. 7G–I). However, exogenous
rmWnt3a in cooperation with endogenous Rspo2 can induce Wnt/
β-catenin activation in mesenchymal explants (Fig. 7I). Furthermore,
loss of the Rspo2 gene sensitizes a dosage effect of the Lrp6 gene
(Fig. 3). This genetic epistasis suggests that Wnt signaling activity
mediated by the Lrp6 receptor is synergized by the presence of Rspo2
and that a cooperative interaction between Rspo2 and Wnt ligands
exists. Therefore, it is reasonable to speculate that Rspo2 may
cooperatively act with ectodermal-derivedWnts, and it is worthwhile
to test this hypothesis in the future.
Regulation of gene expression via signaling interactions between the BA1
ectoderm and mesenchyme
How does Rspo2-mediated Wnt/β-catenin signaling activation in
the BA1 ectoderm and mesenchyme regulate gene expression? Our
explant experiments further revealed that two distinct gene regula-
tory pathways exist in the BA1. In the ﬁrst regulatory pathway, Msx1
andMsx2 expression is directly regulated by Wnt/β-catenin signaling
in the BA1 mesenchyme likely by cooperative activation by both
Rspo2 and ectoderm-derived Wnts (Figs. 7 and 8). A recent study
identiﬁed that both Msx1 and Msx2 are Wnt/β-catenin signaling
targets in the nasal processes of Lrp6 null mice (Song et al., 2009). In
the same study, activation of Wnt/β-catenin signaling by LiCl
increasedMsx1 andMsx2 expression in the BA1 of wild type embryos
in utero (Song et al., 2009). Interestingly, expression of both genes in
the BA1 of Lrp6 null mice was less affected compared to their
expression in the nasal processes, even though TopGAL expression in
the BA1 of Lrp6 mutant mice was nearly abolished. These results
support our identiﬁcation of Msx1 and Msx2 as Wnt/β-catenin
signaling targets. In addition to the direct regulation by Rspo2,
reducedMsx1 andMsx2 expression may be partly due to the reduced
Bmp4 level in the BA1 of Rspo2−/− mice (Fig. 6).
In the second pathway, activation of the Dlx5/6 and Hand2 genes in
the BA1 mesenchyme is independent of Wnt/β-catenin signaling. In
the same mesenchymal explants in which Msx1 and Msx2 were
efﬁciently induced, we failed to detect any induction of Dlx5/6 or
Hand2 expression (Fig. 7J). Edn1–Ednra signaling activates the Dlx5/6
and Hand2 genes in the BA1 (Ozeki et al., 2004; Thomas et al., 1998).
Three results, (i) a reduced Edn1 expression in Rspo2−/−mice (Fig. 6),
(ii) a robust induction of Edn1 by Rspo2 in ectodermal explants
(Fig. 7K), and (iii) Dlx5/6 and Hand2 gene activation by the EDN1
peptide in mesenchymal explants (Fig. 7L), strongly support the
model in which Edn1 induced by Rspo2 in the BA1 ectoderm activates
Fig. 8. A proposed model for Rspo2-mediated Wnt/β-catenin signaling and gene regulation in the mandibular BA1. Gene regulation conﬁrmed by the present and previous studies is
indicated by solid black arrows. A potential regulation is indicated by red dashed line. Decrease of cell survival signals (white color) and expansion of Gsc expression (black color) is
presented as a gradient. The oral side surface ectoderm is presented.
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be noted that the EDN1 gene was recently identiﬁed as a direct target
gene of canonical Wnt/β-catenin signaling in human colorectal cancer
cells (Kim et al., 2005b). In mice lacking the GSK-3β gene, Edn1 level
was signiﬁcantly up-regulated (Kapoor et al., 2008). Therefore, it is
reasonable to speculate that the mouse Edn1 gene is also the direct
target of Rspo2-mediated Wnt/β-catenin signaling in the BA1
ectoderm.
The previous ﬁnding that Fgf8 efﬁciently induces Edn1 expression
(Trumpp et al., 1999) suggests an additional possibility that Rspo2-
induced Fgf8 can activate Edn1 expression. Recently, the Fgf8 gene
was identiﬁed as a direct Wnt/β-catenin signaling target during tooth
development (Wang et al., 2009). Based on these ﬁndings, we propose
amodel in which Rspo2 can directly regulate a set of genes viaWnt/β-
catenin signaling in the BA1 mesenchyme and also activate other
signaling cues such as Edn1 and Fgf8 in the BA1 ectoderm, sub-
sequently activating a different set of genes in the BA1 mesenchyme
(Fig. 8).
Regulation of regional patterning within the BA1 by Rspo2
Down-regulation of gene expression in the mandibular BA1 of
Rspo2−/− embryos appears to occur with a regional speciﬁcity in the
lateral–medial (proximal–distal) and oral–aboral (rostral–caudal)
axes (Fig. 8). Expression of Dlx5, Dlx6, Hand1, Hand2, Msx1, and
Msx2 were all affected in the oral–medial region (Fig. 5). Because Dlx
family genes are implicated in lateral–medial (or proximal–distal)
patterning within the mandibular BA1 (Depew et al., 2002; Jeong
et al., 2008), our data indicate that Rspo2-induced Wnt/β-catenin
signaling is critical for patterning of Dlx5 and Dlx6-speciﬁc domain of
the mandibular BA1. Consistent with this notion, some skeletal
defects of Dlx5 or Dlx6 null mutant mice such as the absence of the
coronoid process and shortenedmandible andMeckel's cartilagewere
shared by those of Rspo2−/− mice (Depew et al., 1999; Jeong et al.,
2008).
In addition to lateral–medial patterning regulation, Rspo2−/−
embryos also showed a disruption in oral–aboral (or rostral–caudal)
patterning of themandibular BA1. Aboral mandibular BA1-speciﬁc Gsc
gene expression was expanded more orally in Rspo2−/− embryos
(Fig. 5M and N). Therefore, Rspo2-mediated Wnt/β-catenin signaling
is required for the repression of Gsc expression (and maybe aboral
identity) in the oral domain. Currently, it is unknownwhether Rspo2-
mediated Wnt/β-catenin signaling is directly involved in this
repression or whether secondary signaling induced byWnt/β-catenin
signaling regulates the repression. Previously, Fgf8 was shown toregulate oral–aboral polarity and repressed Gsc expression in
conjunction with its target gene, Lhx8 (formerly known Lhx7),
specifying oral mesenchyme in the BA1 (Tucker et al., 1999b). Thus,
reduced Fgf8 expression in Rspo2−/− may lead to reduced Lhx8
expression in the oral domain and consequently expansion of Gsc
expression may occur.
Disruption of oral–aboral gradient of cell survival factor(s) in the BA1 of
Rspo2−/− embryos
A signiﬁcant higher level of apoptosis was detected in the aboral–
medial mesenchyme cells in the mandibular BA1 of Rspo2−/−
embryos compared to the oral–medial mesenchymal cells (Fig. 6).
What causes cell apoptosis in the aboral region? Loss of Fgf8 in oral
ectoderm or pharmacological inhibition of Fgf signaling revealed a key
role of Fgf8 signaling in survival and outgrowth of themandibular BA1
mesenchyme (Mandler and Neubuser, 2001; Trumpp et al., 1999).
Fgf8 expression in the oral–medial region of the BA1 ectoderm was
signiﬁcantly reduced in Rspo2−/− embryos (Figs. 4 and 6). Fgf8 is
recently identiﬁed as a Wnt/β-catenin signaling target in mouse
genitalia and tooth development (Miyagawa et al., 2009; Wang et al.,
2009). Therefore, in the most plausible scenario, Fgf8 protein gradient
established in an oral to aboral direction within the mandibular BA1
mesenchyme is likely disrupted in Rspo2−/− embryo. We presume
that reduction of the Fgf8 protein from the oral ectodermwill create a
steeper gradient; thus, mesenchymal cells in the aboral side may be
outside the boundary of active Fgf8 environment and fail to survive
(Fig. 8). In addition to Fgf8, other secreted factors such as Edn1 and
Bmps can play a role as cell survival factors as Edn1 and Bmp4
expression in the oral side ectoderm was reduced in Rspo2−/−
embryos (Fig. 6). Furthermore, it is also possible that Rspo2 itself acts
as a cell survival factor. It would be interesting to determine which
molecules can rescue cell apoptosis phenotype in Rspo2−/− BA1.
Cleft palate in Rspo2−/− mice: an implication to human Pierre Robin
Sequence (PRS)
Cleft palate with/without cleft lip is among themost common birth
defects in humans, and cleft palate is also commonly observed in both
spontaneous and targeted mouse mutants (Schutte and Murray,
1999; Stanier and Moore, 2004). The development of the secondary
palate involves palatal shelf outgrowth to vertical direction, elevation
of the palatal shelves to horizontal direction, midline fusion of the
palatal shelves and the disappearance of midline epithelial seam (Chai
andMaxson, 2006; Jiang et al., 2006). Defects occurring at any of these
12 Y.-R. Jin et al. / Developmental Biology 352 (2011) 1–13developmental steps can lead to cleft of secondary palate. In Rspo2−/−
mice, a delayed and asynchronous elevation of the palatal shelves
prevents timely fusion of the opposing palatal shelves and subse-
quently causes cleft palate observed at birth (Fig. 1). The failure of
horizontal elevation of the palatal shelves is probably caused by
mandibular hypoplasia that produces less mandibular-mediated
mechanical force and causes substantially smaller oral cavity, thus
preventing the proper growth and movements of the tongue and
palatal shelves. This interpretation is strongly supported by the facts
that shorter and smaller Meckel's cartilage and small tongue was
evident in Rspo2−/− embryos at E12.5 to E14.5 (Figs. 1 and S2). It is
also possible that reduced growth of the upper jaw in Rspo2−/− mice
partly contributes to the cleft palate (Fig. 2O). The palatal shelves
isolated from Rspo2−/− mice before fusion retained a normal fusion
capability in ex vivo culture (Fig. S3), suggesting that there are no
intrinsic defects of the fusion process in the Rspo2−/− palatal shelves.
Coexistence of mandibular hypoplasia, small tongue, and cleft
palate in Rspo2−/−mice is phenotypically reminiscent of Pierre Robin
Sequence (PRS, also termed Robin Sequence) in human, a disease
status characterized bymandibular retrognathia (normal size receded
mandible), micrognathia (abnormally small mandible), glossoptosis
(rearward and downward displacement of the tongue), and cleft
palate (Cohen, 1999; Evans et al., 2006; Houdayer et al., 2001;
Jakobsen et al., 2006; Schubert et al., 2005). Amodel for the etiology of
the cleft palate defect in individuals with PRS is that the small or
abnormally positioned mandible prevents normal positioning of the
tongue, thereby interfering palatal shelf elevation and subsequent
fusion (Cohen, 1999; Evans et al., 2006; Houdayer et al., 2001;
Jakobsen et al., 2006; Schubert et al., 2005). In addition to the
previously reportedmousemodels of PRS (Juriloff et al., 2006; Murray
et al., 2007; Satokata andMaas, 1994), Rspo2−/−mice provide another
PRS model. It is warranted to determine if mutations in the human
RSPO2 gene are associated with PRS.
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